The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury

European Journal of Pharmacology

Volumn 478, Issue 2-3, 2003, Pages 131-137

  Wu, Wei Ping ^a   Hao, Jing Xia ^a   Xu, Xiao Jun ^a   Wiesenfeld Hallin, Zsuzsanna ^a   Koek, Wouter ^b   Colpaert, Francis C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT1A receptor; Analgesia; Neuropathic pain; Serotonin

Indexed keywords

3 CHLORO 4 FLUOROPHENYL [4 FLUORO 4 [[(5 METHYLPYRIDIN 2 YLMETHYL)AMINO]METHYL]PIPERIDIN 1 YL]METHADONE; F 13640; SEROTONIN 1A AGONIST; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; ISCHEMIA; LUMBAR SPINE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD INJURY; TREATMENT OUTCOME;

EID: 0142169056     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.047     Document Type: Article

References (40)

1. Arnér S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23. Bonica J.J. Introduction: semantic, epidemiologic and educational issues. Casey K.L. Pain and Central Nervous System Disease: The Central Pain Syndromes. 1991;13-30 Raven Press, New York.
2. Bonica J.J. Introduction: semantic, epidemiologic and educational issues. Casey K.L. Pain and Central Nervous System Disease: The Central Pain Syndromes. 1991;13-30 Raven Press, New York.
3. Bruins Slot L.A., Tarayre J.P., Koek W., Ribet J.P., Colpaert F.C. Experimental conditions for the continuous subcutaneous infusion of four central analgesics in rats. Pharmacol. Biochem. Behav. 72:2002;943-951.
4. Bruins Slot L.A., Koek W., Tarayre J.P., Colpaert F.C. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel central analgesic, F 13640. Eur. J. Pharmacol. 466:2003;271-279.
5. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
6. Colpaert F.C. Narcotic cue, narcotic analgesia, and the tolerance problem: the regulation of sensitivity to drug cues and to pain by an internal cue processing model. Colpaert F.C., Rosecrans J. Stimulus Properties of Drugs: Ten Years of Progress. 1978;301-321 Elsevier/North-Holland Biomedical Press, Amsterdam.
7. Colpaert F.C. System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol. Rev. 48:1996;355-402.
8. Colpaert F.C., Frégnac Y. Paradoxical signal transduction in neurobiological systems. Mol. Neurobiol. 24:2001;145-168.
9. 1A receptor activation: a new mechanism of profound central analgesia. Neuropharmacology. 43:2002;945-958.
10. Corbett D., Thornhill J. Temperature modulation (hypothermic and hyperthermic conditions) and its influence on histological and behavioural outcomes following cerebral ischemia. Brain Pathol. 10:2000;145-152.
11. Deseure K., Koek W., Colpaert F.C., Adriaensen H. 5-HT1A receptor agonist F 13640 attenuates mechanical allodynia in rat model of trigeminal neuropathic pain. Eur. J. Pharmacol. 456:2002;21-57.
12. 1A agonist, F 13640 attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain. J. Pharmacol. Exp. Ther. 306:2003;1-10.
13. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology. 121:1995;1-26.
14. Faden A.I., Gannon A., Basbaum A.I. Use of serotonin immunocytochermistry as a maker of injury severity after experimental spinal trauma in rats. Brain Res. 450:1988;94-100.
15. Finnerup N.B., Johannesen I.L., Sindrup S.H., Bach F.W., Jensen T.S. Pharmacological treatment of spinal cord injury pain. Yezierski R.P., Burchiel K.J. Spinal Cord Injury Pain: Assessment, Mechanisms, Management. 2002;341-351 IASP Press, Seattle.
16. Hao J.-X., Xu X.-J. Treatment of chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists. Pain. 66:1996;279-285.
17. Hao J.-X., Xu X.-J., Aldskogius H., Sieger Å., Wiesenfeld-Hallin Z. Allodynia-like effect in rat after ischemic spinal cord injury photochemically induced by laser irradiation. Pain. 45:1991;175-185.
18. Hao J.-X., Xu X.-J., Yu Y.-X., Sieger Å., Wiesenfeld-Hallin Z. Baclofen reverses the hypersensitivity of dorsal horn wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia: implications for a tonic GABAergic inhibitory control of myelinated fiber input. J. Neurophysiol. 68:1992;392-396.
19. Jensen T.S. An improved understanding of neuropathic pain. Eur. J. Pain. 6:2002;3-11.
20. Ji R.R., Woolf C.J. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol. Dis. 8:2001;1-10.
21. Katz J., Kavanagh B.P., Sandler A.N., Nierenberg H., Boylan J.F., Friedlander M., Shaw B.F. Preemptive analgesia. Clinical evidence of neuroplasticity contribution to postoperative pain. Anesthesiology. 77:1992;439-446.
22. 1A receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats. Neuroscience. 106:2001;547-555.
23. Loeser J.D. Gereralized pain syndromes: pain in spinal cord injury patients. Loeser J.D. Bonica's Management of Pain. 3rd ed. 2000;613-620 Lippincott, Philadelphia.
24. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
25. 1A agonist, 8-OH-DPAT, in the rats reflects induction of spontaneous tail-flicks. Neurosci. Lett. 107:1989;227-232.
26. 1A receptor-mediated activity. J. Pharmacol. Exp. Ther. 256:1991;973-982.
27. Portenoy R.K. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J. Pain Symptom Manag. 11:1996;203-217.
28. Puke M.J., Wiesenfeld-Hallin Z. The differential effects of morphine and the alpha 2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesth. Analg. 77:1993;104-109.
29. Rowbotham M. The debate over opioids and neuropathic pain. Kalsom E., McQuay H., Wiesenfeld-Hallin Z. Opioids Sensitivity of Chronic Noncencer Pain. 1999;207-318 IASP Press, Seattle.
30. Seltzer Z., Cohn S., Ginzburg R., Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain. 45:1991;69-75.
31. Siddall P.J., Yezierski R.P., Loeser J.D. Taxonomy and epidemiology of spinal cord injury pain. Yezierski R.P., Burchiel K.J. Spinal Cord Injury Pain: Assessment, Mechanisms, Management. 2002;9-24 IASP Press, Seattle.
32. Sloper J.J., Johnson P., Powell T.P. Selective degeneration of interneurons in the motor cortex of infant monkeys following controlled hypoxia: a possible cause of epilepsy. Brain Res. 198:1980;204-209.
33. Smith G.D., Harrison S.M., Wiesman J., Elliott P.J., Birch P.J. Pre-emptive administration of clonidine prevents development of hyperalgesia to mechanical stimuli in a model of mononeuropathy in the rat. Brain Res. 632:1993;16-20.
34. Wiesenfeld-Hallin Z., Hao J.-X., Xu X.-J. Mechanisms of central pain. Jensen T.S., Turner J.A., Wiesenfeld-Hallin Z. Progress in Pain Research and Management. Proceedings of the 8th World Congress on Pain. vol. 8:1996;575-589 IASP Press, Seattle.
35. Woolf C.J. Recent advances in the pathophysiology of acute pain. Br. J. Anaesth. 63:1989;139-146.
36. Woolf C.J., Chong M.-S. Preemptive analgesia: treating postoperative pain by preventing the establishment of central sensitization. Anesth. Analg. 77:1993;362-379.
37. Xu X.J., Hao J.X., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain. 48:1992;279-290.
38. Xu X.J., Hao J.-X., Wiesenfeld-Hallin Z. Physiological and pharmacological characterization of a rat model of spinal cord injury pain after spinal ischemia. Yezierski R.P., Burchiel K.J. Spinal Cord Injury Pain: Assessment, Mechanisms, Management. 2002;175-188 IASP Press, Seattle.
39. Yezierski R.P. Pathophysiology and animal models of spinal cord injury pain. Yezierski R.P., Burchiel K.J. Spinal Cord Injury Pain: Assessment, Mechanisms, Management. 2002;117-136 IASP Press, Seattle.
40. Zhang A.-L., Hao J.-X., Sieger Å., Xu X.-J., Wiesenfeld-Hallin Z., Grant G., Aldskogius H. Decreased GABA immunureactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Res. 656:1994;187-190.